venclexta
(Venetoclax)AbbVie Inc.
Usage: VENCLEXTA is indicated for treating adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It is also used in combination with azacitidine, decitabine, or low-dose cytarabine for newly diagnosed acute myeloid leukemia (AML) in adults aged 75 or older, or with significant comorbidities.